5 research outputs found
Pimobendan improves clinical signs in short term compared to digoxin or placebo in dogs with heart failure due to chronic degenerative mitral valve disease
Background: Chronic degenerative mitral valve disease (CDMVD) continues to be the most common cause of heart failure (HF) in small breed dogs. Pimobendan (PIMO) is a mixed action drug with inotropic and vasodilator properties and is widely used to treat heart disease in dogs. Therefore, PIMO increases cardiac output, reduces both preload and afterload and increases myocardial contractility without increasing energy consumption and myocardial oxygen. Digoxin (DIG) is a cardiac glycoside acting through inhibition of the sarcolemmal Na+/K+ ATPase pump, hence increasing intracellular calcium. It exerts benefi cial effects on left ventricular function, symptoms and exercise tolerance. The purpose of this prospective, randomized, double blind clinical trial was to evaluate the clinical response and QoLQ in heart failure (HF) dogs treated with digoxin or pimobendan in addition to conventional therapy (furosemide and benazepril). Materials, Methods & Results: Inclusion criteria: dogs in class III or stabilized class IV (NYHA). Exclusion criteria: use of positive inotrope and antiarrhythmic, presence of atrial fi brillation, renal or hepatic disease or neoplasia. Thirty three dogs were included and randomly assigned to DIG (n = 11), PIMO (n = 14) and placebo (PL) (n = 8) and followed up weekly. Data was evaluated for days zero, 7, 14 and 28. Increasing score was assigned to each variable depending on worsening of clinical evaluation (history and physical exam, QoLQ and echocardiogram (echo).Three dogs died during treatment due to worsening of HF, one of PL group and two of DIG group; furthermore, one of PIMO group was censored due to worsening of heart failure. There was no signifi cant difference between and within groups for echo and radiography. PL and DIG groups did not show any signifi cant difference throughout the 28 days of treatment. PIMO group showed lower physical exam score and increased early mitral infl ow velocity on day 28. Serum creatinine increased on days 14 and 28 compared to baseline, but within normal limits. The groups were similar within each evaluation day. Discussion: This is the fi rst short term prospective randomized double blind study comparing PIMO to DIG or PL additionally to conventional therapy (ACEi and furosemide) for dogs with HF due to CDMVD. It was observed an early signifi cant clinical improvement in dogs receiving PIMO compared to those receiving DIG or PL. The increase in early mitral infl ow velocity (E-wave) on day 28 for PIMO group is suggestive of diastolic dysfunction improvement, but this is only one variable related to diastolic function. Creatinine concentration increased in PIMO group, although it remained within normal range. In the present study, although all the three groups received furosemide, only PIMO group showed increase in blood creatinine between baseline and days 7 and 28. This result must be explored in later studies. Regarding the exercise intolerance assessment in a QoLQ, it must be aware that the owner evaluation is strongly infl uenced by the level of exercise that the dog is regularly submitted. Considering that most of the times, small breed dogs in a more advanced age is probably more sedentary and this fact surely precludes the owner to assess the exercise capacity. A more objective evaluation of the exercise tolerance should be considered in further clinical trials. Probably because of the small number of animals included in this study, differences in other studied variables were not found. The short-term follow-up of these patients may also have infl uenced the lack of differences among groups. Considering that stronger clinical evidence is needed to guide clinical decisions, longer prospective studies are also needed to compare the effects of DIG and PIMO, as well as to consider the benefi ts of the use or not of DIG associated with PIMO for dogs in HF due to CDMVD.Funding. This project was fi nancially supported by FAPESP - São Paulo Research Foundation, process number 08/57620-2
Relationship between plasma levels of Nt-proBNP and diastolic ventricular function assessed by pulsed tissue Doppler echocardiography in obese dogs
A obesidade é uma doença nutricional crescente em humanos e de alta prevalência nos cães. Este distúrbio nutricional e decorrente, principalmente, de um balanço energético inadequado. O excesso de peso pode exacerbar uma doença preexistente e predispor ao desenvolvimento de outros problemas de saúde, como Diabetes mellitus, aumento dos níveis de colesterol e triglicérides, doenças hepáticas, lesões osteoarticulares, hipertensão, alterações cardíacas e respiratórias. Em medicina humana, a associação entre hiperinsulinemia, hiperlipidemia, hiperleptinemia, hipertensão arterial, hipertrofia ventricular e disfunção cardíaca demonstra que a obesidade e um fator de risco para a doença cardiovascular. O aminoterminal peptídeo natriurético tipo B (Nt- proBNP) é um marcador útil de disfunção ventricular nas doenças cardíacas em humanos, bem como em cães e gatos. No entanto, ainda não está claro como interpretar os níveis de Nt- proBNP em pacientes obesos, visto que os níveis deste peptídeo parecem ter correlação negativa com o índice de massa corpórea. A disfunção diastólica é comumente observada em indivíduos obesos e pode ser detectada precocemente por meio de ecocardiograma Doppler tecidual pulsado. Assim, considerando que os diversos estudos corn Nt- proBNP em humanos obesos são controversos e a inexistência de estudos em animais obesos, o objetivo deste estudo foi avaliar o possível papel dos peptídeos natriuréticos como marcadores pré-clínicos de doença cardíaca na obesidade canina e sua relação com os parâmetros de função diastólica avaliados pelo Doppler tecidual pulsado. Para isto, selecionaram-se 49 cães com escore de condição corporal normal (ECC 5) e 48 obesos (ECC 8 e 9), pareados com relação ao gênero, raça e idade. Os cães obesos apresentaram concentração de Nt- proBNP major que os cães com ECC5/9, e alterações em algumas variáveis ecocardiográficas de função diastólica de VE, avaliadas pelo Doppler tecidual pulsado. Também foi observado aumento na relação Ef/Em associado a alta concentração de Nt-proBNP, sugerindo aumento na pressão de enchimento do ventrículo esquerdo em cães obesos.Obesity is an increasing nutritional disease in humans, and highly prevalent in dogs. This nutritional disturbance is a consequence of an inadequate energetic balance. Weight excess may exacerbate a pre-existing disease and predisposes to the development of other health problems as diabetes mellitus, increased colesterol and triglyceride levels, hepatic diseases, osteoarticular diseases, hypertension, cardiac and respiratory problems. In human medicine, the association between hyperinsulinemia, hyperlipidemia, hyperleptinemia, arterial hypertension, ventricular hypertrophy and cardiac disfunction demonstrates that obesity is a risk factor for cardiovascular disease. Type B aminoterminal natriuretic peptide (Nt- proBNP) is a useful marker of ventricular dysfunction in heart disease in humans, as well as in dogs and cats. Nonetheless, it is still unclear how to interpret the levels of Nt-proBNP in obese patients, because it has been negatively correlated to body mass index. Diastolic dysfunction is frequently observed in obese patients and may be detected early by pulsed tissue Doppler imaging (TDI). Therefore, considering that controversial results in several studies on Nt-proBNP in obese humans, and the lack of studies in obese animals, the purpose of this study was to evaluate the possible role of Nt-proBNP as preclinical marker of cardiac disease in obese dogs, and the relationship with diastolic function parameters assessed by pulsed TDI. Foully-nine dogs with ideal body score condition (BCS5/9) and 48 obese dogs (BCS 8 and 9/9), were selected, paired for gender, breed/size and age. A higher Nt-proBNP concentration was found in obese dogs in relation to BCS 5/9 dogs, and some changes in echocardiographic variables of diastolic function, assessed by pulsed TDI. There was also increase Ef/Em ratio associated with a higher Nt-proBNP levels, suggesting an increased filling pressure of left ventricle in obese dogs
Relationship between plasma levels of Nt-proBNP and diastolic ventricular function assessed by pulsed tissue Doppler echocardiography in obese dogs
A obesidade é uma doença nutricional crescente em humanos e de alta prevalência nos cães. Este distúrbio nutricional e decorrente, principalmente, de um balanço energético inadequado. O excesso de peso pode exacerbar uma doença preexistente e predispor ao desenvolvimento de outros problemas de saúde, como Diabetes mellitus, aumento dos níveis de colesterol e triglicérides, doenças hepáticas, lesões osteoarticulares, hipertensão, alterações cardíacas e respiratórias. Em medicina humana, a associação entre hiperinsulinemia, hiperlipidemia, hiperleptinemia, hipertensão arterial, hipertrofia ventricular e disfunção cardíaca demonstra que a obesidade e um fator de risco para a doença cardiovascular. O aminoterminal peptídeo natriurético tipo B (Nt- proBNP) é um marcador útil de disfunção ventricular nas doenças cardíacas em humanos, bem como em cães e gatos. No entanto, ainda não está claro como interpretar os níveis de Nt- proBNP em pacientes obesos, visto que os níveis deste peptídeo parecem ter correlação negativa com o índice de massa corpórea. A disfunção diastólica é comumente observada em indivíduos obesos e pode ser detectada precocemente por meio de ecocardiograma Doppler tecidual pulsado. Assim, considerando que os diversos estudos corn Nt- proBNP em humanos obesos são controversos e a inexistência de estudos em animais obesos, o objetivo deste estudo foi avaliar o possível papel dos peptídeos natriuréticos como marcadores pré-clínicos de doença cardíaca na obesidade canina e sua relação com os parâmetros de função diastólica avaliados pelo Doppler tecidual pulsado. Para isto, selecionaram-se 49 cães com escore de condição corporal normal (ECC 5) e 48 obesos (ECC 8 e 9), pareados com relação ao gênero, raça e idade. Os cães obesos apresentaram concentração de Nt- proBNP major que os cães com ECC5/9, e alterações em algumas variáveis ecocardiográficas de função diastólica de VE, avaliadas pelo Doppler tecidual pulsado. Também foi observado aumento na relação Ef/Em associado a alta concentração de Nt-proBNP, sugerindo aumento na pressão de enchimento do ventrículo esquerdo em cães obesos.Obesity is an increasing nutritional disease in humans, and highly prevalent in dogs. This nutritional disturbance is a consequence of an inadequate energetic balance. Weight excess may exacerbate a pre-existing disease and predisposes to the development of other health problems as diabetes mellitus, increased colesterol and triglyceride levels, hepatic diseases, osteoarticular diseases, hypertension, cardiac and respiratory problems. In human medicine, the association between hyperinsulinemia, hyperlipidemia, hyperleptinemia, arterial hypertension, ventricular hypertrophy and cardiac disfunction demonstrates that obesity is a risk factor for cardiovascular disease. Type B aminoterminal natriuretic peptide (Nt- proBNP) is a useful marker of ventricular dysfunction in heart disease in humans, as well as in dogs and cats. Nonetheless, it is still unclear how to interpret the levels of Nt-proBNP in obese patients, because it has been negatively correlated to body mass index. Diastolic dysfunction is frequently observed in obese patients and may be detected early by pulsed tissue Doppler imaging (TDI). Therefore, considering that controversial results in several studies on Nt-proBNP in obese humans, and the lack of studies in obese animals, the purpose of this study was to evaluate the possible role of Nt-proBNP as preclinical marker of cardiac disease in obese dogs, and the relationship with diastolic function parameters assessed by pulsed TDI. Foully-nine dogs with ideal body score condition (BCS5/9) and 48 obese dogs (BCS 8 and 9/9), were selected, paired for gender, breed/size and age. A higher Nt-proBNP concentration was found in obese dogs in relation to BCS 5/9 dogs, and some changes in echocardiographic variables of diastolic function, assessed by pulsed TDI. There was also increase Ef/Em ratio associated with a higher Nt-proBNP levels, suggesting an increased filling pressure of left ventricle in obese dogs
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies
Background: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies.
Methods: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to define two geoeconomic regions: middle-income countries (MICs) and high-income countries (HICs). ARDS was defined according to the Berlin criteria. Descriptive statistics were used to compare patients in MICs versus HICs. The primary outcome was the use of low tidal volume ventilation (LTVV) for the first 3 days of mechanical ventilation. Secondary outcomes were key ventilation parameters (tidal volume size, positive end-expiratory pressure, fraction of inspired oxygen, peak pressure, plateau pressure, driving pressure, and respiratory rate), patient characteristics, the risk for and actual development of acute respiratory distress syndrome after the first day of ventilation, duration of ventilation, ICU length of stay, and ICU mortality.
Findings: Of the 7608 patients included in the original studies, this analysis included 3852 patients without ARDS, of whom 2345 were from MICs and 1507 were from HICs. Patients in MICs were younger, shorter and with a slightly lower body-mass index, more often had diabetes and active cancer, but less often chronic obstructive pulmonary disease and heart failure than patients from HICs. Sequential organ failure assessment scores were similar in MICs and HICs. Use of LTVV in MICs and HICs was comparable (42·4% vs 44·2%; absolute difference -1·69 [-9·58 to 6·11] p=0·67; data available in 3174 [82%] of 3852 patients). The median applied positive end expiratory pressure was lower in MICs than in HICs (5 [IQR 5-8] vs 6 [5-8] cm H2O; p=0·0011). ICU mortality was higher in MICs than in HICs (30·5% vs 19·9%; p=0·0004; adjusted effect 16·41% [95% CI 9·52-23·52]; p<0·0001) and was inversely associated with gross domestic product (adjusted odds ratio for a US$10 000 increase per capita 0·80 [95% CI 0·75-0·86]; p<0·0001).
Interpretation: Despite similar disease severity and ventilation management, ICU mortality in patients without ARDS is higher in MICs than in HICs, with a strong association with country-level economic status